SCHEMBL13639148

SCHEMBL13639148

CBc1cccc(OCC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ NOTUM Q6P988 2/20 0.45
▸ NQO1 P15559 1/20 0.44
▸ LTA4H P09960 1/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ RXRA P19793 1/20 0.42
▸ RXRB P28702 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ MAP4K4 O95819 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL28781953 0.98 TP53 (0.53) TP53CYP3A4NOTUMNQO1LTA4H
SCHEMBL23018998 0.82 TP53 (0.53) TP53CYP3A4NOTUMNQO1LTA4H
1,3-Diethoxybenzene SCHEMBL1100167 0.80 TP53 (0.71) TP53CYP3A4NQO1LTA4HMAPK1
SCHEMBL13626610 0.78 MAOB (0.62) SMN1; SMN2
SCHEMBL12464036 0.77 ACHE (0.52) CYP3A4CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL9260410 0.74 RXRA (0.66) TP53CYP3A4NOTUMNQO1LTA4H
SCHEMBL29426410 0.74 RXRA (0.66) TP53CYP3A4NOTUMNQO1LTA4H
SCHEMBL1204104 0.74 TP53 (0.63) TP53CYP3A4NOTUMNQO1LTA4H
SCHEMBL9488001 0.74 TP53 (0.63) TP53CYP3A4NQO1LTA4HMAPK1
SCHEMBL23583 0.73 TP53 (0.57) TP53CYP3A4NQO1LTA4HMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481976-B1 8-AZAPROSTAGLANDIN DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2012-11-07 — — EP disclosed
Send feedback